The new world: hematopoietic stem cell transplant during a pandemic.
Curr Opin Hematol
; 28(6): 389-393, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1377995
ABSTRACT
PURPOSE OF REVIEW Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacted every facet of hematopoietic cell transplantation. This article reviews the adjustments to recipient and donor care that occurred in response to this unprecedented event. RECENT FINDINGS:
Transplant centers modified algorithms, patient flow, education, and how we provided care. Our donor center partners reworked how donors were evaluated and products delivered to the transplant center. Our professional societies provided guidelines for patient and donor care and rapidly modified these based upon the never-ending stream of new data learned about SARS-CoV-2. Our research organizations provided rapid analyses to ensure the care modifications necessitated did not have a profound negative impact on our patients or donors.SUMMARY:
The efforts of transplant providers and donor centers worldwide allowed patients to receive the transplant needed with assurances that they were receiving the best care available despite the worldwide challenge.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Donantes de Tejidos
/
Algoritmos
/
Guías de Práctica Clínica como Asunto
/
Trasplante de Células Madre Hematopoyéticas
/
Receptores de Trasplantes
/
SARS-CoV-2
/
COVID-19
Tipo de estudio:
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Curr Opin Hematol
Asunto de la revista:
Hematología
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
MOH.0000000000000680
Similares
MEDLINE
...
LILACS
LIS